Advantages and Emerging Problems of Novel Treatments for Transthyretin Cardiac Amyloidosis.

Advantages and Emerging Problems of Novel Treatments for Transthyretin Cardiac Amyloidosis. Circ J. 2019 Dec 06;: Authors: Okumura T, Murohara T PMID: 31813898 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31813898?dopt=Abstract

Source: Circulation Journal - December 5, 2019 Category: Cardiology Authors: Okumura T, Murohara T Tags: Circ J Source Type: research

More News: Amyloidosis | Cardiology | Japan Health | Science